-
101por Vietri, Jeffrey T, Myers, Kelley H, Huang, Liping, Snow, Vincenza, Hauber, Brett, Arguedas, Adriano, Cane, Alejandro D, Tort, Maria J, Pierce, Anna, Poulos, Christine“…HCPs responded to direct elicitation questions to assess preferences for each of the potential pneumococcal vaccination recommendations considered above. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
102“…RESULTS: In 2003, the total study population was 41,059, of which 12,907 (31%) received influenza vaccine of these, 4,447 (11%) were administered the pneumococcal vaccine. In 2004, 14,799 (34%) individuals received the influenza vaccine and 8,843 (21%) the pneumococcal vaccine and in 2005 16,926 (39%) individuals were given the influenza vaccine and 12,340 (28%) the pneumococcal vaccine. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
103por Tanskanen, Antti, Nillos, Leilani T, Lehtinen, Antti, Nohynek, Hanna, Sanvictores, Diozele Hazel M, Simões, Eric AF, Tallo, Veronica L, Lucero, Marilla GEnlace del recurso
Publicado 2012
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
104por Kuhlmann, Alexander, Theidel, Ulrike, Pletz, Mathias W, von der Schulenburg, J-Matthias Graf“…The effectiveness of individual pneumococcal vaccination in adults was adjusted for expected indirect effects due to the vaccination in infants. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
105por Naito, ToshioEnlace del recurso
Publicado 2013
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
106por Wilmore, Stephanie M.S., Philip, Keir E., Cambiano, Valentina, Bretherton, Christopher P., Harborne, Josephine E., Sharma, Aditi, Jayasena, Shyama D.“…The Department of Health advises that these patients receive influenza and pneumococcal vaccinations at regular intervals—once yearly and every five years, respectively. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
107“…This review summarizes the serotype epidemiology of pneumococcal disease pre- and post-introduction of PCV7, available post-marketing surveillance data following the introduction of higher valency pneumococcal vaccines (PCV10, PCV13) and future prospects for the development of new pneumococcal vaccines.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
108
-
109por Iyer, Anita S., Khaskhely, Noor M., Leggat, David J., Ohtola, Jennifer A., Saul-McBeth, Jessica L., Khuder, Sadik A., Westerink, M. A. Julie“…A better understanding of the role of TNF receptors could contribute to the design of improved pneumococcal vaccines. TRIAL REGISTRATION: ClinicalTrials.gov NCT02515240…”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
110por Harris, John A., Moniz, Michelle H., Iott, Brad, Power, Robyn, Griggs, Jennifer J.“…Compared to normal weight patients, combined odds ratio of pneumococcal vaccination were 1.20 (95 % CI 1.13–1.27) for obese patients. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
111
-
112
-
113“…This review aimed at presenting this candidate of pneumococcal vaccine and results in an animal model.…”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
114por Recher, Mike, Hirsiger, Julia R., Bigler, Marc B., Iff, Martin, Lemaître, Barbara, Scherer, Kathrin, Häusermann, Peter, Siegrist, Claire-Anne, Berger, Christoph T.Enlace del recurso
Publicado 2018
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
115por Kuchenbecker, Ulrike, Chase, Daniela, Reichert, Anika, Schiffner-Rohe, Julia, Atwood, Mark“…INTRODUCTION: In Germany, a 23-valent polysaccharide pneumococcal vaccine (PPSV23) is recommended for elderly (60+) and patients 16+ with chronic diseases not associated with immune suppression. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
116por Willem, Lander, Blommaert, Adriaan, Hanquet, Germaine, Thiry, Nancy, Bilcke, Joke, Theeten, Heidi, Verhaegen, Jan, Goossens, Herman, Beutels, Philippe“…These observations are independent of the assumption that PPV23 has 0% efficacy against non-invasive pneumococcal pneumonia. Pneumococcal vaccination would be most cost-effective in Belgium, when achieving high uptake with PPV23 in 75–84 year olds, as well as by negotiating a lower market-conform PPV23 price to improve uptake and cost-effectiveness.…”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
117“…BACKGROUND: Some children are prone to recurrent invasive pneumococcal disease (rIPD) and of these, some respond insufficiently to standard pneumococcal vaccination. Little is known about how to handle these children and if they benefit from additional vaccination. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
118“…This is the first report of global deployment of a pneumococcal vaccination program for welders within a multi‐national corporation. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
119“…The overall prevalence of influenza and pneumococcal vaccination in this population were 47.8% and 2.8%, respectively. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
120Physicians’ awareness and practice toward influenza and pneumococcal vaccines for high-risk patients“…RESULTS: The overall knowledge of physicians about influenza and pneumococcal vaccines was inadequate and was more toward pneumococcal vaccine, in spite their respectable knowledge about the target population. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto
